Marc Antoine Aimé

IMCAS | Asia 2025

par Marc Antoine Aimé | Mai 2, 2025 | Congress

IMCAS Asia 2025, Booth 95 | Level 3 Paris from 30 January to 1 February 2025. Visit us at Booth 95 Level 3 and discover how our regenerative solutions are transforming aesthetics and anti-ageing medicine. Let’s connect at our booth to discuss how Regen Lab is...

TERMIS – EU

par Marc Antoine Aimé | Avr 28, 2025 | Congress

Meet Us at TERMIS EU 2025 in Freiburg! | Booth 22 from 20 to 23 May 2025. Join us from 20–23 May 2025 at the TERMIS EU Conference at Messe Freiburg, Germany. Visit us at Booth 22 to discover the latest innovations in regenerative medicine and tissue engineering. We...

REGENPRP™-HA COMBINATION FOR KNEE OA: Barac 2018

par Marc Antoine Aimé | Mar 25, 2025 | Clinical Study osteoarthritis PRP-HA

REGENPRP™-HA COMBINATION FOR KNEE OA BARAC 2018 The new treatment approach in knee osteoarthritis: Efficacy of cellular matrix combination of platelet rich plasma with hyaluronic acid versus two different types of hyaluronic acid (HA). Cellular Matrix technology: a...

ACNE & KELOID SCARS

par Marc Antoine Aimé | Mar 21, 2025 | Clinical Study Dermal

ACNE & KELOID SCARS ACNE SCARS  Application of regenerative medicine in treatment of acne scars. The efficacy of a nanofat and plasma rich-platlets injection and fractional CO2 laser resurfacing was evaluated in 30 patients. • The authors showed that the...

SKIN REVITALISATION

par Marc Antoine Aimé | Mar 21, 2025 | Clinical Study Dermal

SKIN REVITALISATION Face and neck revitalisation with platelet-rich plasma. In this case series of 23 patients, the authors evaluated if there are real outcomes, benefits and side effects following a standardised PRP injection protocol DGS was calculated by comparing...

« Entrées précédentes



RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.



RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.



RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.



RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).



Hyaluronic Acid

Coming Soon



Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.



Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.



Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.